Molecular profiling of rare thymoma using next-generation sequencing: meta-analysis

Kostic Peric, Jelena; Cirkovic, Andja; Srzentic Drazilov, Sanja; Samardzic, Natalija; Skodric Trifunovic, Vesna; Jovanovic, Dragana; Pavlovic, Sonja

doi:10.2478/raon-2023-0013

Abstract

Background

Thymomas belong to rare tumors giving rise to thymic epithelial tissue. There is a classification of several forms of thymoma: A, AB, B1, B2, B3, thymic carcinoma (TC) and thymic neuroendocrine thymoma. In this meta-analysis study, we have focused on thymoma using articles based on the disease’s next-generation sequencing (NGS) genomic profiling.

Materials and methods

We conducted a systematic review and meta-analysis of the prevalence of studies that discovered the genes and variants occurring in the less aggressive forms of the thymic epithelial tumors. Studies published before 12^th December 2022 were identified through PubMed, Web of Science (WoS), and SCOPUS databases. Two reviewers have searched for the bases and selected the articles for the final analysis, based on well-defined exclusion and inclusion criteria.

Results

Finally, 12 publications were included in the qualitative as well as quantitative analysis. The three genes, GTF2I, TP53, and HRAS, emerged as disease-significant in the observed studies. The Odds Ratio for all three extracted genes GTF2I (OR = 1.58, CI [1.51, 1.66] p < 0.00001), TP53 (OR = 1.36, CI [1.12, 1.65], p < 0.002), and HRAS (OR = 1.02, CI [1.00, 1.04], p < 0.001).

Conclusions

According to obtained data, we noticed that the GTF2I gene exhibits a significant prevalence in the cohort of observed thymoma patients. Moreover, analyzing published articles NGS has suggested GTF2I, TP53, and HRAS genes as the most frequently mutated genes in thymoma that have pathogenic single nucleotide variants (SNV) and Insertion/Deletion (InDel), which contribute to disease development and progression. These variants could be valuable biomarkers and target points specific to thymoma.

References

Cowen D, Richaud P, Mornex F, Bachelot T, Jung GM, Mirabel X, et al. Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer. Radiother Oncol 1995; 34: 9-16. doi: 10.1016/0167-8140(94)01493-m
Open DOI Search in Google Scholar Back to article
Levine GD, Rosai J. Thymic hyperplasia and neoplasia: a review of current concepts. Human Pathology 1978; 9: 495-515. doi: 10.1016/s0046-8177(78)80131-2
Open DOI Search in Google Scholar Back to article
Falkson CB, Bezjak A, Darling G, Gregg R, Malthaner R, Maziak DE, et al. The management of thymoma: a systematic review and practice guideline. J Thorac Oncol 2009; 4: 911-9. doi: 10.1097/jto.0b013e3181a4b8e0
Open DOI Search in Google Scholar Back to article
Okumura M, Ohta M, Tateyama H, Nakagawa K, Matsumura A, Maeda H, et al. The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients. Cancer 2002; 94: 624-32. doi: 10.1002/cncr.10226
Open DOI Search in Google Scholar Back to article
Engels EA, Pfeiffer RM. Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 2003; 105: 546-51. doi: 10.1002/ijc.11099
Open DOI Search in Google Scholar Back to article
Tomaszek S, Wigle DA, Keshavjee S, Fischer S. Thymomas: review of current clinical practice. Ann Thorac Surg 2009; 87: 1973-80. doi: 10.1016/j. athoracsur.2008.12.095
Open DOI Search in Google Scholar Back to article
Chau NG, Kim ES, Wistuba I. The multidisciplinary approach to thymoma: combining molecular and clinical approaches. J Thorac Oncol 2010; 5: S313-7. doi: 10.1097/JTO.0b013e3181f20d9a
Open DOI Search in Google Scholar Back to article
Miyamoto K, Acoba JD. Thymomas and thymic carcinomas: a review on pathology, presentation, staging, treatment, and novel systemic therapies. EMJ Respir 2017; 5: 100-7. doi: 10.33590/emjrespir/10310358
Open DOI Search in Google Scholar Back to article
Peric J, Samaradzic N, Skodric Trifunovic V, Tosic N, Stojsic J, Pavlovic S, et al. Genomic profiling of thymoma using a targeted high-throughput approach. Arch Med Sci 2020. doi: 10.5114/aoms.2020.96537
Open DOI Search in Google Scholar Back to article
Slatko BE, Gardner AF, Ausubel FM. Overview of next-generation sequencing technologies. Curr Protoc Mol Biol 2018; 122: e59. doi: 10.1002/cpmb.59
Open DOI Search in Google Scholar Back to article
Duncavage EJ, Abel HJ, Szankasi P, Kelley TW, Pfeifer JD. Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia. Mod Pathol 2012; 25: 795-804. doi: 10.1038/modpathol.2012.29
Open DOI Search in Google Scholar Back to article
Xu H, DiCarlo J, Satya RV, Peng Q, Wang Y. Comparison of somatic mutation calling methods in amplicon and whole exome sequence data. BMC Genomics 2014; 15: 244. doi: 10.1186/1471-2164-15-244
Open DOI Search in Google Scholar Back to article
Chakravarty D, Gao J, Phillips SM, Kundra R, Zhang H, Wang J, et al. OncoKB: A Precision Oncology Knowledge Base. JCO Precis Oncol 2017; 2017: PO.17.00011. doi: 10.1200/PO.17.00011
Open DOI Search in Google Scholar Back to article
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidem 2009; 62: e1-34. doi: 10.1016/j.jclinepi.2009.06.006
Open DOI Search in Google Scholar Back to article
Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page M J, et al. A Cochrane handbook for systematic reviews of interventions. Cochrane handbook for systematic reviews of interventions. 2019. (cited 2022 Dec 19). Available at: https://training.cochrane.org/handbook
Search in Google Scholar Back to article
Cohrain Training. RevMan 5. (accessed 2021 Aug 3). Available at: https://training.cochrane.org/online-learning/core-software-cochrane-reviews/revman/revman-5-download
Search in Google Scholar Back to article
Girard N, Basse C, Schrock A, Ramkissoon S, Killian K, Ross JS. Comprehensive genomic profiling of 274 thymic epithelial tumors unveils oncogenic pathways and predictive biomarkers. Oncologist 2022; 27: 919-29. doi: 10.1093/oncolo/oyac115
Open DOI Search in Google Scholar Back to article
Szpechcinski A, Szolkowska M, Winiarski S, Lechowicz U, Wisniewski P, Knetki-Wroblewska M. Targeted next-generation sequencing of thymic epithelial tumours revealed pathogenic variants in KIT, ERBB2, KRAS, and TP53 in 30% of thymic carcinomas. Cancers 2022; 14: 3388. doi: 10.3390/cancers14143388
Open DOI Search in Google Scholar Back to article
GeneCards^® The Human Gene Database. (Updated: 2023 Jan 10). Available at: https://www.genecards.org/
Search in Google Scholar Back to article
Müllauer L. GTF2I gene mutation – a driver of thymoma pathogenesis. Mediastinum 2017; 1: 11. doi: 10.21037/med.2017.11.03
Open DOI Search in Google Scholar Back to article
Feng Y, Lei Y, Wu X, Huang Y, Rao H, Zhang Y, et al. GTF2I mutation frequently occurs in more indolent thymic epithelial tumors and predicts better prognosis. Lung Cancer 2017; 110: 48-52. doi: 10.1016/j.lungcan.2017.05.02022
Open DOI Search in Google Scholar Back to article
Radovich M, Pickering CR, Felau I, Ha G, Zhang H, Jo H, et al. The integrated genomic landscape of thymic epithelial tumors. Cancer Cell 2018; 33: 244-58.e10. doi: 10.1016/j.ccell.2018.01.003
Open DOI Search in Google Scholar Back to article
Liu D, Zhang P, Zhao J, Yang L, Wang W. Identification of molecular characteristics and new prognostic targets for thymoma by multiomics analysis. BioMed Res Int 2021; 2021: Article ID 5587441, 1-15. doi: 10.1155/2021/5587441
Open DOI Search in Google Scholar Back to article
TCGA’s Study of Thymoma. (cited 2022 Dec 5). Available at: https://www.cancer.gov/about-nci/organization/ccg/research/structural-genomics/tcga/studied-cancers/thymoma
Search in Google Scholar Back to article
Venuta F, Rendina EA, Anile M, de Giacomo T, Vitolo D, Coloni GF. Thymoma and thymic carcinoma. Gen Thorac Cardiovasc Surg 2012; 60: 1-12. doi: 10.1007/s11748-011-0814-0
Open DOI Search in Google Scholar Back to article
Petrini I, Meltzer PS, Kim IK, Lucchi M, Park KS, Fontanini G, et al. A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. Nature Genetics 2014; 46: 844-9. doi: 10.1038/ng.3016
Open DOI Search in Google Scholar Back to article
Higuchi R, Goto T, Hirotsu Y, Yokoyama Y, Nakagomi T, Otake S, et al. Primary driver mutations in GTF2I specific to the development of thymomas. Cancers 2020; 12: 1-12. doi: 10.3390/cancers12082032
Open DOI Search in Google Scholar Back to article
Liang NX, Liu L, Huang C, Liu HS, Guo C, Li J, et al. Transcriptomic and mutational analysis discovering distinct molecular characteristics among chinese thymic epithelial tumor patients. Front Oncol 2021; 11: 647512. doi: 10.3389/fonc.2021.647512
Open DOI Search in Google Scholar Back to article
Hafner A, Bulyk ML, Jambhekar A, Lahav G. The multiple mechanisms that regulate p53 activity and cell fate. Nat Rev Mol Cell Biol 2019; 20: 199-210. doi: 10.1038/s41580-019-0110-x
Open DOI Search in Google Scholar Back to article
Marx A, Belharazem D, Lee DH, Popovic ZV, Reissfelder C, Schalke B, et al. Molecular pathology of thymomas: implications for diagnosis and therapy. Virchows Arch 2021; 478: 101-10. doi: 10.1007/s00428-021-03068-8
Open DOI Search in Google Scholar Back to article
Chen K, Che JM, Zhang XF, Jin RS, Xiang J, Han DP, et al. Next-generation sequencing in thymic epithelial tumors uncovered novel genomic aberration sites and strong correlation between TMB and MSH6 single nucleotide variations. Cancer Letters 2020; 476: 75-86. doi: 10.1016/j.canlet.2020.02.001
Open DOI Search in Google Scholar Back to article
Xu S, Li XF, Zhang HY, Zu LL, Yang LQ, Shi T, et al. Frequent genetic alterations and their clinical significance in patients with thymic epithelial tumors. Front Oncol 2021; 11: 667148. doi: 10.3389/fonc.2021.667148
Open DOI Search in Google Scholar Back to article
Jovanovic D, Markovic J, Ceriman V, Peric J, Pavlovic S, Soldatovic I. Correlation of genomic alterations and PD-L1 expression in thymoma. J Thorac Dis 2020; 12: 7561-70. doi: 10.21037/jtd-2019-thym-13
Open DOI Search in Google Scholar Back to article
Enkner F, Pichlhöfer B, Zaharie AT, Krunic M, Holper TM, Janik S, et al. Molecular profiling of thymoma and thymic carcinoma: genetic differences and potential novel therapeutic targets. Pathol Oncol Res 2017; 23: 551-64. doi: 10.1007/s12253-016-0144-8
Open DOI Search in Google Scholar Back to article
Rajan A, Girard N, Marx A. State of the art of genetic alterations in thymic epithelial tumors. J Thorac Oncol 2014; 9: S131-S6. doi: 10.1097/JTO.0000000000000298
Open DOI Search in Google Scholar Back to article
Sakane T, Murase T, Okuda K, Saida K, Masaki A, Yamada T, et al. A mutation analysis of the EGFR pathway genes, RAS, EGFR, PIK3CA, AKT1 and BRAF, and TP53 gene in thymic carcinoma and thymoma type A/B3. Histopathology 2019; 75: 755-66. doi: 10.1111/his.13936
Open DOI Search in Google Scholar Back to article